• SPX
  • $5,962.90
  • 0.24 %
  • $14.19
  • DJI
  • $44,112.92
  • 0.55 %
  • $242.56
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,265.61
  • 1.43 %
  • $116.34
  • IXIC
  • $18,975.61
  • 0.02 %
  • $3.19

Halozyme says €2 billion takeover of Evotech would create leader in drug discovery

By MarketWatch   |   Nov 18, 2024 at 07:49 AM EST
Halozyme says €2 billion takeover of Evotech would create leader in drug discovery

Halozyme proposed a non-binding takeover of Evotech SE at 11 euros a share, valued at €2 billion. The combined company aims for $2 billion in revenue by 2025, creating a unique pharma services company with synergies and growth potential.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.